FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a thiazole derivative of formula 1
,
as an activator of peroxisome proliferator activated receptor δ (PPARδ), or to its pharmaceutically acceptable salts.
EFFECT: production of the pharmaceutical composition for preventing and treating arteriosclerosis or hyperlipidemia, for providing higher level of high-density protein (HDP), for preventing and treating diabetes, obesity, for strengthening muscles or endurance, for improving memory or preventing and treating dementia or Alzheimer's disease or Parkinson's disease containing such thiazole derivative.
7 cl, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORGANOSELENIUM COMPOUNDS AND THEIR USE | 2005 |
|
RU2371437C2 |
| ARYL COMPOUNDS AS PPAR LIGANDS AND THEIR APPLICATION | 2007 |
|
RU2444514C2 |
| THIAZOLE DERIVATIVES AS PPAR-DELTA LIGANDS AND OBTAINMENT METHOD | 2006 |
|
RU2392274C2 |
| SELENAZOLE DERIVATIVE, HAVING LIGAND ACTIVATING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), METHOD FOR PRODUCTION THEREOF AND USE OF CHEMICAL COMPOUNDS | 2010 |
|
RU2510394C1 |
| ENANTIOMER OF SUBSTITUTED PHENYLPROPIONIC ACID AND A METHOD FOR PRODUCTION THEREOF, COMPOSITION THEREOF AND USE THEREOF | 2017 |
|
RU2735524C2 |
| PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ ACTIVATING AGENT | 2007 |
|
RU2435764C2 |
| DIARYL COMPOUNDS WITH BRIDGE BOND | 2002 |
|
RU2297409C2 |
| AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2185381C2 |
| COMPOUNDS POSSESSING ACIVATING ACTION ON PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SUBTYPES (PPARs), AND METHOD FOR PRODUCING AND USING ABOVE COMPOUNDS | 2011 |
|
RU2546117C2 |
| DERIVATIVES OF DIARYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2267484C2 |
